# UK Home Infusion Therapy Devices Market > UK Home Infusion Therapy Devices Market Research Report By Device Type (Infusion Pumps, Syringe Pumps, Ambulatory Pumps, Enteral Feeding Pumps), By Therapy Type (Antibiotic Therapy, Chemotherapy, Nutrition Therapy, Pain Management), By End User (Hospitals, Home Care Settings, Nursing Homes) and By Components (Infusion Set, Catheters, Accessories, Software Solutions) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 5.08% - **2024:** $ 426.9 Million - **2025:** $ 448.59 Million - **2035:** $ 736 Million - **Key Players:** Baxter International Inc (US), B. Braun Melsungen AG (DE), Fresenius Kabi AG (DE), Medtronic plc (IE), Smiths Medical (US), Terumo Corporation (JP), ICU Medical Inc (US), Halyard Health Inc (US) **Report ID:** MRFR/Pharma/49004-HCR · **Pages:** 200 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** August 24, 2026 **URL:** https://www.marketresearchfuture.com/reports/uk-home-infusion-therapy-devices-market-50761 --- ## Market Summary ## **UK Home Infusion Therapy Devices Market Overview** As per MRFR analysis, the UK Home Infusion Therapy Devices Market Size was estimated at 896.33 (USD Million) in 2023. The UK Home Infusion Therapy Devices Market Industry is expected to grow from 944.3 (USD Million) in 2024 to 1,667.8 (USD Million) by 2035. The UK Home Infusion Therapy Devices Market CAGR (growth rate) is expected to be around 5.307% during the forecast period (2025 - 2035). ### **Key UK Home Infusion Therapy Devices Market Trends Highlighted** The UK Home Infusion Therapy Devices Market is witnessing significant trends driven by several factors. One of the key market drivers is the increasing preference for home healthcare as patients seek treatments in a more comfortable and familiar environment. The National Health Service (NHS) in the UK has been actively promoting home-based care, allowing patients to manage their therapies while simultaneously reducing the burden on hospital facilities. This shift is complemented by advancements in technology that have made infusion devices more patient-friendly and accessible, enhancing the overall user experience. There are several opportunities to be explored in the UK market, particularly in the development of smart infusion devices that offer features like remote monitoring and data tracking.These advancements complement the efforts of the UK government to digitize healthcare since it allows easier remote monitoring of patients and timely intervention by healthcare providers. Furthermore, the increasing elderly population in the UK represents a significant market opportunity since this population tends to have several chronic conditions that could be treated with home infusion therapies. There is evidence that more attention is being paid to the application of telehealth in home infusion therapy. This combination enables the healthcare practitioner to render more tailored care remotely, thus minimizing patient hospital visits. Furthermore, there is a rising awareness of the cost-effectiveness of home infusion compared to traditional inpatient settings, encouraging both patients and healthcare systems to adopt this treatment method more widely. Overall, the UK Home Infusion Therapy Devices Market is evolving dynamically, fueled by a combination of patient preferences and technological advancements. Source Primary Research, Secondary Research, MRFR Database and Analyst Review ## **UK Home Infusion Therapy Devices Market Drivers** ### **Rising Demand for Home Healthcare Solutions** The growing trend towards home healthcare solutions is a significant driver for the UK Home Infusion Therapy Devices Market Industry. With the increasing preference for patients to receive care at home rather than in traditional healthcare settings, the market is experiencing a notable boost. According to the National Health Service (NHS), over 800,000 patients in the UK are currently benefiting from home healthcare services, leading to a demand for devices that facilitate safe and effective home infusion therapy. Major organizations, such as the Department of Health and Social Care, are actively encouraging the shift towards home-based therapies. Moreover, government policies aimed at reducing hospital overcrowding and improving patient quality of life further support this market's growth. As healthcare facilities shift resources towards outpatient care, it is anticipated that the uptake of home infusion devices will significantly rise, especially as the population ages and chronic diseases become more prevalent. ### **Technological Advancements in Infusion Devices** Technological innovations are propelling the UK Home Infusion Therapy Devices Market Industry significantly. Advanced infusion devices equipped with smart technology, such as dosage calculators and connectivity features, are becoming increasingly popular. The UK government has invested heavily in Research and Development (R&D) in the medical device field, fostering an environment conducive to innovation. For example, increased funding through the NHS Innovation Accelerator has led to the development of next-generation infusion therapies aimed at enhancing patient safety. With the adoption of telehealth technologies, healthcare providers can now monitor patients remotely, ensuring effective management of infusion therapies. As a result, this tech-driven approach will likely encourage more patients to opt for home infusion therapies, ultimately driving market growth. ### **Increased Prevalence of Chronic Diseases** The increasing prevalence of chronic diseases in the UK is a critical market driver for the Home Infusion Therapy Devices Market Industry. According to the NHS, chronic conditions such as diabetes, heart disease, and respiratory illnesses affect approximately 15 million people in the UK, and this number is expected to rise due to factors such as an aging population and lifestyle changes. The rise in chronic disease cases necessitates ongoing treatment, often through infusion therapies, prompting both patients and healthcare providers to seek home-based alternatives. Organizations spearheading the fight against these chronic conditions, including Diabetes UK and the British Heart Foundation, highlight the need for accessible and efficient treatment options. As more patients require long-term therapies, the demand for home infusion devices is anticipated to surge. ## **UK Home Infusion Therapy Devices Market Segment Insights** ### **Home Infusion Therapy Devices Market Device Type Insights** The UK Home Infusion Therapy Devices Market shows a significant focus on various device types that cater to the increasing need for home-based healthcare solutions. With a shift towards patient-centered care, managing chronic conditions at home utilizing infusion therapy is becoming prevalent. Infusion pumps are pivotal in this market, providing precise and controlled medication delivery, which is essential for patients requiring continuous therapy. Their adoption is primarily driven by the growing incidence of diabetes, oncology cases, and the necessity for long-term intravenous treatments. Syringe pumps also play a crucial role in the UK Home Infusion Therapy Devices Market, offering versatility and reliability for pediatric and neonatal applications where dosage accuracy is critical. The use of syringe pumps is expanding as healthcare providers emphasize the importance of administering medications with minimal risk of error, especially in vulnerable patient populations. Ambulatory pumps are gaining traction as they facilitate mobility for patients, allowing them to receive treatment outside the hospital setting. This aspect resonates well with the rising trend of outpatient care and self-management, as it empowers patients to maintain their daily activities while undergoing therapy. Enteral feeding pumps contribute to the nutritional needs of patients who cannot ingest food orally, emphasizing the growing awareness of nutritional therapy at home. The increasing prevalence of conditions necessitating enteral feeding, such as neurological disorders and certain cancers, drives their demand. Overall, the diverse range of device types within the UK Home Infusion Therapy Devices Market illustrates the commitment to enhancing the quality of life for patients through accessible and user-friendly home care solutions. These devices cater to a growing population in the UK who are increasingly reliant on home-based treatment options, thus playing a vital role in the market's expansion and evolution. Source Primary Research, Secondary Research, MRFR Database and Analyst Review ### **Home Infusion Therapy Devices Market Therapy Type Insights** The UK Home Infusion Therapy Devices Market is witnessing significant growth in the Therapy Type segment, which encompasses various treatment modalities, including Antibiotic Therapy, Chemotherapy, Nutrition Therapy, and Pain Management. Antibiotic Therapy is crucial for patients requiring long-term treatment for chronic infections at home, allowing for enhanced recovery and reduced hospital stays. Chemotherapy, commonly administered in a home setting, enables cancer patients to receive necessary treatments in the comfort of their own homes, potentially improving adherence and quality of life. Nutrition Therapy also holds a vital place as it supports patients with malnutrition or illnesses requiring supplemental feeding, emphasizing the increased demand for enteral and parenteral nutrition solutions. Pain Management remains a prominent area, addressing the needs of patients with chronic pain conditions and ensuring ongoing relief and care continuity. This diverse segmentation showcases the growing trend towards personalized home care solutions in the UK healthcare system, as patients and healthcare providers alike recognize the importance of creating tailored treatment plans that accommodate individual patient needs while promoting lifestyle and well-being.The robust advancements in technology and increasing awareness around home healthcare are further driving the expansion of these therapy types across the market. ### **Home Infusion Therapy Devices Market End User Insights** The End User segment of the UK Home Infusion Therapy Devices Market includes key settings such as Hospitals, Home Care Settings, and Nursing Homes. Hospitals serve as a critical environment for the deployment of infusion therapy devices, mainly due to the complexity of care provided for acute conditions and the need for advanced technologies during patient treatment. Home Care Settings have gained increasing importance as more patients choose to receive therapies in the comfort of their own homes, driven largely by a preference for personalized care and the rising cost of hospital stays. This trend aligns with the broader healthcare strategy in the UK to promote more patient-centered approaches and enhance quality of life. Nursing Homes play a significant role as well, catering to an aging population that requires continuous infusion therapies for chronic ailments, thereby augmenting the demand for specialized equipment and trained staff. The growing emphasis on delivering efficient and timely healthcare services across these settings further illustrates the importance of the End User segment in the overall landscape of the UK Home Infusion Therapy Devices Market. ### **Home Infusion Therapy Devices Market Components Insights** The Components segment of the UK Home Infusion Therapy Devices Market is integral to the overall landscape, facilitating efficient and effective patient care. This segment encompasses a diverse array of essential components such as Infusion Sets, Catheters, Accessories, and Software Solutions, all designed to enhance the infusion therapy experience. Infusion Sets play a crucial role in ensuring precise delivery of medication, which is vital for patient safety and treatment efficacy. Catheters are significant as they provide access to the patient's vascular system, allowing for prolonged therapy without discomfort. Accessories, including safety devices and storage solutions, contribute to the operational functionality and efficiency of infusion processes. Furthermore, Software Solutions are gaining prominence, enabling healthcare providers to monitor patient data in real-time, which is particularly relevant in the context of home-based therapy. The growing emphasis on home healthcare tools in the UK, supported by government initiatives to reduce hospital visits, bodes well for this segment, creating opportunities for enhanced patient compliance and satisfaction.As such, each component plays a pivotal role in the delivery and efficacy of home infusion therapy in the UK, catering to the evolving needs of both healthcare professionals and patients. ## **UK Home Infusion Therapy Devices Market Key Players and Competitive Insights** The competitive landscape of the UK Home Infusion Therapy Devices Market is shaped by the rising prevalence of chronic diseases, an aging population, and the increasing demand for cost-effective healthcare solutions. This sector is characterized by a diverse range of players who offer various devices designed to deliver medication, hydration, and nutrition directly into patients' homes. As the focus shifts towards patient-centric care, manufacturers are tasked with innovating and enhancing their products to meet the evolving needs of healthcare providers and patients alike. Regulatory frameworks and technological advancements are also pivotal in defining the competitive strategies of these companies within this market. Moog Inc. has established a significant presence in the UK Home Infusion Therapy Devices Market through its commitment to innovation and quality. The company specializes in developing advanced infusion systems known for their reliability, safety, and precision. Moog Inc.’s strength lies in its dedicated research and development efforts, which enable the launch of enhanced products that cater to specific patient needs, making them desirable among healthcare professionals. In the competitive sphere, Moog Inc. is recognized for its robust supply chain and strategic partnerships with healthcare institutions, allowing them to effectively distribute their devices and maintain a sustained customer base. Becton Dickinson is another key player in the UK Home Infusion Therapy Devices Market, known for its comprehensive portfolio that includes infusion pumps, needle-free injection systems, and various accessories tailored for home therapy use. The company's strengths are amplified by its significant investment in research and development, leading to the introduction of innovative solutions that improve patient outcomes and streamline healthcare processes. Becton Dickinson emphasizes strong market presence through collaborations, strategic mergers, and acquisitions that bolster its capabilities and expand its product offerings. The extensive distribution network and established reputation in the UK healthcare system further consolidate Becton Dickinson's position in the market, allowing them to cater to hospitals, clinics, and directly to patients effectively. ### **Key Companies in the UK Home Infusion Therapy Devices Market Include** ## **UK Home Infusion Therapy Devices Market Industry Developments** The UK Home Infusion Therapy Devices Market has recently witnessed significant developments, particularly in the expansion of product offerings and increasing market valuations. Companies such as Moog Inc., Becton Dickinson, and Medtronic are focusing on enhancing their device capabilities to cater to the growing patient demand for home-based care. As of September 2023, Baxter International announced the launch of an innovative infusion pump designed for outpatient use, reflecting the rising shift towards home healthcare solutions. Furthermore, Smiths Medical and Fresenius Kabi have been actively enhancing their Research and Development efforts to introduce advanced devices that improve patient outcomes and ease of use. In terms of mergers and acquisitions, notable activity has included ICU Medical's acquisition of a specialty infusion product line from a competitor in July 2023, which is expected to bolster its market presence. Additionally, Terumo Corporation reported plans in August 2023 to expand its operations in the UK, aligning with the growing trend of individualized patient care. Over the past two years, the market has shown a steady increase in valuation due to these advancements and heightened awareness of home healthcare, which has become increasingly critical in light of ongoing healthcare reforms within the UK. ## **UK Home Infusion Therapy Devices Market Segmentation Insights** ### **Home Infusion Therapy Devices Market Device Type Outlook** ### **Home Infusion Therapy Devices Market Therapy Type Outlook** ### **Home Infusion Therapy Devices Market End User Outlook** ### **Home Infusion Therapy Devices Market Components Outlook** ## Market Drivers ### Supportive Government Policies Supportive government policies and initiatives are playing a crucial role in the expansion of the home infusion-therapy-devices market. The UK government has been actively promoting home healthcare solutions to enhance patient care and reduce healthcare costs. Initiatives aimed at integrating home infusion therapies into standard care practices are gaining traction, with funding allocated to support these programs. This governmental backing not only facilitates access to home infusion therapies but also encourages innovation within the market. As policies continue to evolve in favor of home-based care, the home infusion-therapy-devices market is likely to experience substantial growth. ### Cost-Effectiveness of Home Care The economic advantages associated with home care are significantly influencing the home infusion-therapy-devices market. Home infusion therapy is often more cost-effective than hospital stays, reducing overall healthcare expenditures. A study indicates that home-based treatments can save the NHS up to £1,000 per patient compared to traditional inpatient care. This financial incentive encourages healthcare systems to promote home infusion therapies, as they not only enhance patient comfort but also alleviate the burden on hospital resources. As a result, the demand for home infusion-therapy-devices is expected to rise, driven by the need for more economical healthcare solutions. ### Increased Awareness and Education Growing awareness and education regarding home infusion therapies are pivotal in driving the home infusion-therapy-devices market. Healthcare professionals and patients are becoming more informed about the benefits of home-based treatments, leading to a shift in perception. Educational initiatives by healthcare organizations are promoting the advantages of home infusion, such as improved quality of life and reduced hospital visits. This increased awareness is likely to result in a higher acceptance rate of home infusion therapies among patients, thereby expanding the market. As more individuals seek alternatives to traditional hospital care, the demand for home infusion-therapy-devices is expected to grow. ### Rising Prevalence of Chronic Diseases The increasing incidence of chronic diseases in the UK is a primary driver for the home infusion-therapy-devices market. Conditions such as diabetes, cancer, and heart disease necessitate ongoing treatment, often requiring infusion therapies. According to recent data, approximately 15 million people in the UK live with chronic conditions, leading to a heightened demand for home-based care solutions. This trend is likely to continue, as the population ages and the prevalence of these diseases rises. Consequently, healthcare providers are increasingly adopting home infusion therapies to manage patient care effectively, thereby propelling the growth of the home infusion-therapy-devices market. ### Technological Innovations in Infusion Devices Technological advancements in infusion devices are transforming the home infusion-therapy-devices market. Innovations such as smart pumps, mobile applications, and remote monitoring systems enhance the safety and efficacy of home infusion therapies. These devices allow for precise medication delivery and real-time monitoring, which can significantly improve patient outcomes. The integration of technology into home care settings is becoming increasingly prevalent, with a projected growth rate of 10% in the adoption of smart infusion devices over the next five years. This trend indicates a robust future for the home infusion-therapy-devices market, as technology continues to evolve and improve patient care. ## Future Outlook The [Home Infusion Therapy Devices Market](https://www.marketresearchfuture.com/reports/home-infusion-therapy-devices-market-7906) is projected to grow at a 5.08% CAGR from 2025 to 2035, driven by technological advancements and increasing patient preference for home care. **New opportunities:** - Development of integrated telehealth platforms for remote patient monitoring. - Expansion of customizable infusion systems tailored for specific therapies. - Partnerships with home healthcare providers to enhance service delivery and accessibility. By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare dynamics. ## Segment Insights ### By Device Type: Infusion Pumps (Largest) vs. IV Sets (Fastest-Growing) In the UK home infusion-therapy-devices market, the segment distribution shows Infusion Pumps holding the largest market share. IV Sets are gaining traction as they cater to a growing demand for efficient delivery mechanisms, reflecting the evolving patient care needs. Other segments, such as Needles and Cannulas and Syringe Pumps, also contribute to the market, but with relatively smaller shares. The growth trends indicate a rising acceptance of advanced technologies in infusion devices, driven by improved patient outcomes and the increasing prevalence of chronic illnesses requiring home care. The market is further supported by favorable regulations and the introduction of innovative products aimed at enhancing the safety and efficacy of infusion therapy, establishing IV Sets as the fastest-growing segment. Infusion Pumps (Dominant) vs. IV Sets (Emerging) Infusion Pumps remain the dominant force in the market due to their established reputation for delivering precise medication dosages and their integral role in chronic condition management. As hospitals and patients prioritize safety and accuracy, these devices are experiencing steady demand. IV Sets, on the other hand, represent an emerging segment characterized by their adaptability and ease of use in home settings. With the shift towards outpatient care, the innovation in IV Set designs catering to user-friendly applications is helping them to grow rapidly. As healthcare professionals focus on patient-centric solutions, both segments are likely to thrive, albeit with different market dynamics. ### By Application: Antibiotics (Largest) vs. Pain Management (Fastest-Growing) In the UK home infusion-therapy-devices market, the application of antibiotics holds the largest market share among the various segment values. It is widely utilized for treating infections, making it a critical component of home healthcare. In contrast, pain management is emerging rapidly, driven by an increasing number of patients requiring effective pain relief solutions at home, displaying a significant growth trajectory. The growth trends in the application segment are primarily influenced by the aging population and the rising prevalence of chronic conditions requiring long-term treatment. Innovations in infusion technology continue to enhance the safety and efficacy of treatment, supporting the rise of both antibiotics and pain management applications. As patient preferences shift towards home-based solutions, these segments are expected to thrive in the coming years. Antibiotics (Dominant) vs. Pain Management (Emerging) Antibiotics have established themselves as the dominant application within the UK home infusion-therapy-devices market, largely due to their critical role in treating various bacterial infections. This segment benefits from a well-developed regulatory framework and a strong infrastructure for distribution, enabling widespread access for patients. Conversely, pain management is gaining momentum as an emerging segment driven by the need for accessible pain relief options for chronic pain patients. This segment focuses on delivering a diverse range of solutions including continuous and intermittent pain therapy, thereby enhancing patient comfort and quality of life. As healthcare evolves, both segments will play essential roles in ensuring effective home care. ### By End User: Homecare Settings (Largest) vs. Hospitals (Fastest-Growing) In the UK home infusion-therapy-devices market, the distribution of market share among end users shows that homecare settings hold the largest share, reflecting a growing preference for at-home medical care. Hospitals follow closely, benefiting from an established infrastructure for administering infusion therapies. Ambulatory surgical centers and nursing homes contribute to the market but with comparatively smaller shares. This segmentation illustrates how the shift towards patient-centered care is influencing resource allocation in the market. Growth trends indicate that while homecare settings continue to lead, hospitals are quickly emerging as a fast-growing segment. The increase in chronic diseases and the demand for personalized healthcare solutions are significant drivers of this trend. Furthermore, advancements in technology and a growing preference for outpatient care support the expansion of both homecare settings and hospitals. The ability to provide infusions outside traditional settings enhances patient comfort and represents a shift towards more flexible care options. Homecare Settings (Dominant) vs. Hospitals (Emerging) Homecare settings serve as the dominant end user in the UK home infusion-therapy-devices market, reflecting a paradigm shift towards decentralized healthcare. Patients benefit from receiving therapies in the comfort of their homes, which enhances convenience and adheres to personal health needs. This segment is characterized by a rising demand for portable and user-friendly infusion devices. Conversely, hospitals, while currently in an emerging position, are experiencing rapid growth due to advancements in medical technologies and an increasing focus on patient-oriented service delivery. The integration of innovative devices into hospital systems is expediting the adoption of infusion therapies within these facilities. ### By Product: Smart Infusion Pumps (Largest) vs. Portable Infusion Devices (Fastest-Growing) In the UK home infusion-therapy-devices market, the market share is predominantly held by Smart Infusion Pumps, which have emerged as the leading segment due to their advanced features and user-friendly designs. Portable Infusion Devices, while smaller in share, are rapidly increasing in demand as they cater to the growing preference for mobile healthcare solutions. The growth trends are significantly influenced by the rising adoption of home healthcare systems and the increasing prevalence of chronic diseases necessitating continuous infusion therapies. Smart Infusion Pumps are gaining traction among healthcare providers for their precision and safety features, while Portable Infusion Devices are benefiting from technological advancements that enable greater portability and ease of use, making them the preferred choice for patients requiring outpatient therapy. Smart Infusion Pumps (Dominant) vs. Portable Infusion Devices (Emerging) Smart Infusion Pumps dominate the UK home infusion-therapy-devices market due to their sophisticated technology that ensures precise medication delivery, enhancing patient safety and compliance. They are equipped with features like dose error reduction systems and extensive drug libraries, making them essential in both hospital and home settings. On the other hand, Portable Infusion Devices represent an emerging trend, appealing to patients who value mobility and convenience. Their compact design allows for easy transport and administration of infusions at home, aligning with the increasing shift towards patient-centric care. As both segments evolve, their integration into overall healthcare strategies is expected to reshape how infusion therapies are delivered. ## Competitive Benchmarking The home infusion-therapy-devices market is characterized by a dynamic competitive landscape, driven by increasing demand for at-home healthcare solutions and advancements in technology. Key players such as Baxter International Inc (US), B. Braun Melsungen AG (DE), and Fresenius Kabi AG (DE) are strategically positioned to leverage innovation and expand their market presence. Baxter International Inc (US) focuses on enhancing its product portfolio through technological advancements, while B. Braun Melsungen AG (DE) emphasizes partnerships to strengthen its distribution channels. Fresenius Kabi AG (DE) appears to be concentrating on regional expansion, particularly in the UK, to capture a larger share of the growing market. Collectively, these strategies contribute to a competitive environment that is increasingly focused on innovation and customer-centric solutions.In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The market structure is moderately fragmented, with several key players exerting influence over various segments. This fragmentation allows for a diverse range of products and services, catering to the specific needs of healthcare providers and patients alike. The collective influence of these companies shapes the competitive dynamics, as they vie for market share through differentiated offerings and strategic collaborations. In October Baxter International Inc (US) announced the launch of a new infusion pump designed to improve patient safety and streamline workflows in home care settings. This strategic move is significant as it not only enhances Baxter's product offerings but also aligns with the growing trend towards patient-centric care, potentially increasing their market share in the home infusion segment. The introduction of this advanced technology may also set a new standard for safety and efficiency in home infusion therapies. In September B. Braun Melsungen AG (DE) entered into a strategic partnership with a leading telehealth provider to integrate remote monitoring capabilities into its infusion systems. This collaboration is likely to enhance patient engagement and adherence to therapy, reflecting a broader trend towards digital health solutions. By combining their infusion technology with telehealth services, B. Braun may improve patient outcomes and solidify its position in the market. In August Fresenius Kabi AG (DE) expanded its manufacturing capabilities in the UK by investing €20 million in a new facility dedicated to producing infusion devices. This investment underscores Fresenius Kabi's commitment to meeting the increasing demand for home infusion therapies and demonstrates a proactive approach to supply chain optimization. The new facility is expected to enhance production efficiency and reduce lead times, positioning the company favorably in a competitive market. As of November current trends in the home infusion-therapy-devices market include a strong emphasis on digitalization, sustainability, and the integration of artificial intelligence (AI) into healthcare solutions. Strategic alliances are increasingly shaping the competitive landscape, as companies seek to combine their strengths to deliver innovative solutions. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition towards a focus on innovation, technology, and supply chain reliability. This shift may redefine how companies position themselves in the market, emphasizing the importance of delivering high-quality, efficient, and patient-centered care. ## Recent News & Developments The UK Home Infusion Therapy Devices Market has recently witnessed significant developments, particularly in the expansion of product offerings and increasing market valuations. Companies such as Moog Inc., Becton Dickinson, and Medtronic are focusing on enhancing their device capabilities to cater to the growing patient demand for home-based care. As of September 2023, Baxter International announced the launch of an innovative infusion pump designed for outpatient use, reflecting the rising shift towards home healthcare solutions. Furthermore, Smiths Medical and Fresenius Kabi have been actively enhancing their Research and Development efforts to introduce advanced devices that improve patient outcomes and ease of use. In terms of mergers and acquisitions, notable activity has included ICU Medical's acquisition of a specialty infusion product line from a competitor in July 2023, which is expected to bolster its market presence. Additionally, Terumo Corporation reported plans in August 2023 to expand its operations in the UK, aligning with the growing trend of individualized patient care. Over the past two years, the market has shown a steady increase in valuation due to these advancements and heightened awareness of home healthcare, which has become increasingly critical in light of ongoing healthcare reforms within the UK. ## Report Scope | MARKET SIZE 2024 | 426.9(USD Million) | | --- | --- | | MARKET SIZE 2025 | 448.59(USD Million) | | MARKET SIZE 2035 | 736.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.08% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Baxter International Inc (US), B. Braun Melsungen AG (DE), Fresenius Kabi AG (DE), Medtronic plc (IE), Smiths Medical (US), Terumo Corporation (JP), ICU Medical Inc (US), Halyard Health Inc (US) | | Segments Covered | Device Type, Application, End User, Product | | Key Market Opportunities | Integration of advanced telehealth solutions enhances patient monitoring in the home infusion-therapy-devices market. | | Key Market Dynamics | Rising demand for home infusion-therapy-devices driven by technological advancements and evolving patient care preferences in the UK. | | Countries Covered | UK | ## Frequently Asked Questions **Q: What is the current valuation of the UK home infusion-therapy-devices market?** A: The market valuation was $426.9 Million in 2024. **Q: What is the projected market valuation for the UK home infusion-therapy-devices market by 2035?** A: The projected valuation for 2035 is $736.0 Million. **Q: What is the expected CAGR for the UK home infusion-therapy-devices market during the forecast period 2025 - 2035?** A: The expected CAGR is 5.08% during the forecast period. **Q: Which device type segment had the highest valuation in 2024?** A: The IV Sets segment had the highest valuation at $100.0 Million in 2024. **Q: What is the projected valuation for the Infusion Pumps segment by 2035?** A: The Infusion Pumps segment is projected to reach between $85.0 Million and $150.0 Million by 2035. **Q: Which application segment is expected to grow significantly in the UK home infusion-therapy-devices market?** A: The Hydration Therapy application segment is expected to grow, with a valuation projected between $101.9 Million and $166.0 Million by 2035. **Q: What is the valuation range for the Homecare Settings end user segment in 2024?** A: The Homecare Settings end user segment had a valuation range of $200.0 Million to $350.0 Million in 2024. **Q: Which key player is recognized for its leadership in the UK home infusion-therapy-devices market?** A: Baxter International Inc is recognized as a key player in the UK home infusion-therapy-devices market. **Q: What is the projected valuation for Smart Infusion Pumps by 2035?** A: The Smart Infusion Pumps segment is projected to reach between $150.0 Million and $250.0 Million by 2035. **Q: How does the projected growth of the UK home infusion-therapy-devices market compare to its 2024 valuation?** A: The market is expected to grow from $426.9 Million in 2024 to $736.0 Million by 2035, indicating substantial growth. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/uk-home-infusion-therapy-devices-market-50761*